Tanshinone IIA protects against immune-mediated liver injury through activation of t-cell subsets and regulation of cytokines

Tangya Li,Yu Tian,Xiaoyan Qin,Li Yan,Qing-shan Liu

Abstract:Danshen, the dried stems and roots of Salvia miltiorrhiza Bunge, have commonly been used for decades in traditional Chinese medicine for cardiovascular diseases as a circulating anticoagulant [1,2]. Major pharmacological applications of Danshen include dilating cardiocerebral vessels, suppressing aggregation of platelets, improving circulation, removing blood stasis, protecting against ischemic reperfusion injury, and enhancing the tolerance of ischemic tissue to hypoxia [1,3]. In addition, TSN is reported as an antioxidant [4]. Up to the present, 15 classes of biologically active substrates have been extracted from Danshen [2]. Its active ingredients include diterpenoids and phenolic compounds: Tanshinone IIA (TSN), Tanshinone I, cryptotanshinone, Danshensu etc. Liposoluble TSN can be modified into water-soluble sodium TSN sulfonate (STS), which is used in clinics for coronary heart diseases [2]. Evidence shows that Danshensu, the other phenolic component in Danshen, protects against liver injury and hepatic fibrosis [2,5]. It is intriguing to examine if TSN, which has a structure similar to Danshensu, is protective against liver injury and could be a potential therapeutic drug for clinics. Liver injury is found in a variety of liver diseases. Immune-mediated liver injury is often observed when autoreactive T-cells destroy hepatocytes or cholangiocytes

Medicine